Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications.
cancer
cost
financial distress
financial toxicity
oncology
poverty risk
Journal
Annals of oncology : official journal of the European Society for Medical Oncology
ISSN: 1569-8041
Titre abrégé: Ann Oncol
Pays: England
ID NLM: 9007735
Informations de publication
Date de publication:
01 07 2019
01 07 2019
Historique:
pubmed:
3
5
2019
medline:
24
6
2020
entrez:
3
5
2019
Statut:
ppublish
Résumé
Patients experiencing financial distress as a side-effect of cancer are not only reported in the United States, but also in third-party payer healthcare systems in Europe. Since validated survey instruments are a prerequisite for robust and comparable results, we aimed to compile and classify available instruments to enable both a better understanding of the underlying construct of financial toxicity and to facilitate further studies that are adjustable to various healthcare systems. We did a systematic literature search on studies that provide data on perceived cancer-related financial distress experienced by adult patients using PubMed, CINAHL and Web of Science databases up to 2018. We analyzed all detected instruments, items domains and questions with regard to their wording, scales and the domains of financial distress covered. Among 3298 records screened, 41 publications based on 40 studies matched our inclusion criteria. Based on the analysis of 352 different questions we identified 6 relevant subdomains that represent perceptions of and reactions to experienced financial distress: (i) active financial spending, (ii) use of passive financial resources, (iii) psychosocial responses, (iv) support seeking, (v) coping with care or (vi) coping with ones' lifestyle. We found an inconsistent coverage and use of these domains that makes it difficult to compare and quantify the prevalence of financial distress. Moreover, some existing instruments do not reflect relevant domains for patients in third-party payer systems. There is neither a consistent understanding of the construct of financial burden nor do available instruments cover all relevant aspects of a patients' distress perception. We encourage using the identified six domains to further develop survey instruments and adjust them to different health systems.
Identifiants
pubmed: 31046080
pii: S0923-7534(19)31244-X
doi: 10.1093/annonc/mdz140
pmc: PMC6637374
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1061-1070Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology.
Références
Support Care Cancer. 2015 Mar;23(3):889-98
pubmed: 25337681
Cancer. 2008 Feb 1;112(3):616-25
pubmed: 18085642
BMC Cancer. 2012 Apr 24;12:152
pubmed: 22530992
CA Cancer J Clin. 2018 Mar;68(2):153-165
pubmed: 29338071
Cancer. 2014 Oct 1;120(19):3074-81
pubmed: 24889014
Psychooncology. 2011 Jan;20(1):36-43
pubmed: 20186841
PLoS One. 2017 May 18;12(5):e0176470
pubmed: 28545063
J Oncol Pract. 2013 Nov;9(6S):60s-63s
pubmed: 29431038
J Oncol Pract. 2015 Mar;11(2):145-50
pubmed: 25515717
Psychooncology. 2016 Jun;25(6):719-25
pubmed: 26149817
Support Care Cancer. 2013 Dec;21(12):3509-17
pubmed: 23975225
J Clin Oncol. 2016 Mar 20;34(9):980-6
pubmed: 26811521
Support Care Cancer. 2006 Aug;14(8):837-48
pubmed: 16482448
Mater Sociomed. 2012;24(2):112-20
pubmed: 23678317
J Gen Intern Med. 2009 Nov;24 Suppl 2:S446-50
pubmed: 19838848
Aust J Rural Health. 2011 Dec;19(6):298-305
pubmed: 22098213
Surgery. 2015 Jun;157(6):971-82
pubmed: 25934082
J Cancer Surviv. 2016 Apr;10(2):241-50
pubmed: 26188363
J Natl Cancer Inst. 2016 Oct 20;109(2):
pubmed: 27754926
Cancer. 2013 Oct 15;119(20):3710-7
pubmed: 23907958
Biol Blood Marrow Transplant. 2016 Aug;22(8):1504-1510
pubmed: 27184627
Eur J Cancer Care (Engl). 2017 Jan;26(1):
pubmed: 26423576
J Clin Oncol. 2007 Jan 10;25(2):180-6
pubmed: 17210937
Lancet Haematol. 2015 Oct;2(10):e408-16
pubmed: 26686042
Cancer. 2015 Apr 15;121(8):1257-64
pubmed: 25564986
Asian Pac J Cancer Prev. 2015;16(4):1621-5
pubmed: 25743842
Psychooncology. 2007 Dec;16(12):1130-9
pubmed: 17345557
Br J Oral Maxillofac Surg. 2012 Jul;50(5):410-6
pubmed: 22000023
Palliat Med. 2007 Oct;21(7):595-607
pubmed: 17942498
Cancer Pract. 1994 May-Jun;2(3):187-93
pubmed: 8055022
Qual Life Res. 2005 Mar;14(2):373-86
pubmed: 15892426
Eur J Cancer Care (Engl). 2007 Nov;16(6):500-7
pubmed: 17944764
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Support Care Cancer. 2014 Jan;22(1):233-44
pubmed: 24037412
Cancer. 2017 Feb 1;123(3):476-484
pubmed: 27716900
J Clin Oncol. 2015 Jul 1;33(19):2190-6
pubmed: 25987701
J Support Oncol. 2008 Apr;6(4):183-92
pubmed: 18491687
Oncologist. 2013;18(4):381-90
pubmed: 23442307
J Clin Oncol. 2016 Jan 20;34(3):259-67
pubmed: 26644532
Gynecol Oncol. 2012 Mar;124(3):437-43
pubmed: 22138013
J Oncol Pract. 2017 Apr;13(4):e310-e318
pubmed: 28195811
J Oncol Pract. 2016 Jul;12(7):e755-64
pubmed: 27328795
Oncologist. 2015 Oct;20(10):1199-204
pubmed: 26330457
Psychooncology. 2016 Aug;25(8):919-26
pubmed: 26282448
Ann Oncol. 2016 Dec;27(12):2224-2229
pubmed: 27789469
Support Care Cancer. 2016 Feb;24(2):699-709
pubmed: 26143038
Recent Results Cancer Res. 1988;111:231-49
pubmed: 2459750
J Clin Oncol. 2016 May 20;34(15):1732-40
pubmed: 26926678
Cancer. 2014 Oct 15;120(20):3245-53
pubmed: 24954526
J Clin Oncol. 2012 May 10;30(14):1608-14
pubmed: 22412136
Ann Intern Med. 2000 Mar 21;132(6):451-9
pubmed: 10733444
Oncologist. 2015 Sep;20(9):1092-8
pubmed: 26205738
Ann Oncol. 2016 Dec;27(12):2143-2145
pubmed: 27742653
Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):563-70
pubmed: 27020104
Qual Life Res. 2000;9(7):789-800
pubmed: 11297021
J Oncol Pract. 2014 Sep;10(5):332-8
pubmed: 24865220
Biol Blood Marrow Transplant. 2014 Sep;20(9):1375-81
pubmed: 24867778
J Clin Oncol. 2014 Apr 20;32(12):1269-76
pubmed: 24663041
Psychooncology. 2013 Apr;22(4):745-55
pubmed: 22411485
Future Oncol. 2014 Nov;10(14):2189-99
pubmed: 25471033
Patient. 2017 Jun;10(3):295-309
pubmed: 27798816
Support Care Cancer. 2007 Sep;15(9):1051-6
pubmed: 17242911
Support Care Cancer. 2006 Nov;14(11):1077-85
pubmed: 16896878
Med Care. 2014 Nov;52(11):957-62
pubmed: 25304021
J Health Soc Behav. 2006 Mar;47(1):17-31
pubmed: 16583773
Oncologist. 2014 Apr;19(4):414-20
pubmed: 24668333
Expert Rev Pharmacoecon Outcomes Res. 2015;15(4):599-605
pubmed: 26176751
Health Econ. 2005 Dec;14(12):1197-215
pubmed: 15945040
Cancer Nurs. 2013 Jul-Aug;36(4):301-8
pubmed: 23047800
Support Care Cancer. 2016 Oct;24(10):4423-32
pubmed: 27225528